Viking Therapeutics
Stock Forecast, Prediction & Price Target

Viking Therapeutics Financial Estimates

Viking Therapeutics Revenue Estimates

Viking Therapeutics EBITDA Estimates

Viking Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $777.14K
Low: $777.14K
High: $777.14K
avg. 0%
Avg: $38.10M
Low: $38.10M
High: $38.10M
avg. 4802.71%
Avg: $124.95M
Low: $124.95M
High: $124.95M
avg. 227.95%
Avg: $553.86M
Low: $553.86M
High: $553.86M
avg. 343.26%
Net Income
 
% change YoY
$-54.00M
 
N/A
$-67.37M
 
-24.77%
$-85.89M
 
-27.48%
Avg: $-140.77M
Low: $-140.77M
High: $-140.77M
avg. -63.88%
Avg: $-154.99M
Low: $-154.99M
High: $-154.99M
avg. -10.10%
Avg: $-132.19M
Low: $-132.19M
High: $-132.19M
avg. 14.71%
Avg: $49.81M
Low: $49.81M
High: $49.81M
avg. 137.68%
EBITDA
 
% change YoY
$-55.68M
 
N/A
$-70.31M
 
-26.26%
$-100.82M
 
-43.39%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.7
 
N/A
-$0.88
 
-25.71%
-$0.91
 
-3.40%
Avg: -$1.49
Low: -$1.49
High: -$1.49
avg. -63.96%
Avg: -$1.64
Low: -$1.64
High: -$1.64
avg. -10.10%
Avg: -$1.4
Low: -$1.4
High: -$1.4
avg. 14.71%
Avg: $0.53
Low: $0.53
High: $0.53
avg. 137.68%
Operating Expenses
 
% change YoY
$55.68M
 
N/A
$70.35M
 
26.35%
$100.82M
 
43.31%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Viking Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 19.60% in 2025-2028.

We have gathered data from N/A analysts. Their low estimate is -140.77M, average is -140.77M and high is -140.77M.

What is Viking Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 1343.48% in 2025-2028.

We have gathered data from N/A analysts. Their low revenue estimate is $777.14K, average is $777.14K and high is $777.14K.

What is Viking Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 19.58% in 2025-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.49, average is -$1.49 and high is $-1.49.